Close Menu
    What's Hot

    Skye Africa Intelligence and ECSA-HC Sign Memorandum of Understanding to Scale AI-Enabled Health Solutions

    August 5, 2026

    OECD inflation eases to 4.2% as lower energy rates take hold

    August 5, 2026

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026
    • Home
    • Contact Us
    Oran MailOran Mail
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • More
      • News
      • Sports
      • Technology
      • Travel
    Oran MailOran Mail
    Home » AfriSummit 2024: African Health Authorities and Industry Leaders Unite to Discuss Pharma Regulations and Innovations
    Featured News

    AfriSummit 2024: African Health Authorities and Industry Leaders Unite to Discuss Pharma Regulations and Innovations

    November 6, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    PharmaReg and MedDevReg AfriSummit Host 80+ Regional and International Speakers Alongside Over 300 Pharmaceutical and Medical Device Professionals

    MENA Newswire: Cairo, Egypt, 06 November 2024 – Prominent healthcare authorities and industry specialists came together for AfriSummit 2024, a vital 4-day hybrid event dedicated to advancing pharmaceutical and medical device regulations along with interactive trainings in eCTD and Pharmacovigilance, all to achieve a healthier Africa. Set at the Grand Nile Tower, the summit attracted more than 300+ delegates and featured over 80 thought leaders from regulatory, legal, manufacturing, and distribution sectors.

    The Egyptian Drug Authority, which was one of the main authorities present at AfriSummit 2024, had Dr. Rasha Ziada, the EDA Chairman Assistant for Professional Development and Capacity Building Affairs, conduct the opening where she mentioned “Achievement of WHO maturity Level 3 not just a milestone but a responsibility on us, we are responsible in supporting other African countries to reach the same level.” Dr. Rasha has also expressed that “As a regulatory authority, our mission extends beyond safeguarding and overseeing the use of medicines at the national level; it also reaches across Africa.”

    AfriSummit 2024 highlighted innovative approaches to drug trials and approvals, enriched by workshops like eCTD Training and Pharmacovigilance. Dr. Mona Al Moussli, Chairman of AfriSummit, stated, “This year’s AfriSummit was truly extravagant, featuring a remarkable participation of industry leaders. Their insightful presentations underscored the crucial need for harmonization in regulatory practices across Africa, paving the way for a more integrated healthcare landscape.”

    Key dignitaries presented their regulatory insights, underscoring the event’s importance in enhancing compliance and improving healthcare standards. In addition, AfriSummit 2024 was honourably attended by ambassadors and ministers and diplomats from across the African continent.

    Dr. Najiba Al Shezawy, Co-Chairman of AfriSummit, expressed her gratitude for the participation of various African authorities this year, stating, “We deeply appreciate the contributions of all participating African NRAs, whose insights and engagement are crucial for strengthening our regulatory frameworks and fostering collaboration across the continent.”

    Attendees actively engaged in comprehensive roundtable discussions with representatives from key healthcare authorities, fostering an environment of collaboration, which aimed at addressing the regulatory challenges and opportunities facing the pharmaceutical and healthcare sectors.

    The summit affirmed its status as the leading annual gathering for the regulatory affairs in pharmaceutical, medical device and healthcare sectors across Africa, of which are experiencing significant growth.

    As AfriSummit 2024 wrapped up, it sent a powerful message of collaboration and dedication to enhancing healthcare standards across the continent. The event reinforced its position as a crucial platform for fostering cooperation among stakeholders and driving transformative change in the pharmaceutical landscape.

    Related Posts

    Elite Group Holding Strengthens Customer Value Through Strategic Lifestyle Partnerships

    July 16, 2026

    MITHRA Metals advances strategic nickel laterite initiative in Ethiopia

    June 3, 2026

    Pam Golding Properties expands global footprint with Dubai office launch

    May 19, 2026

    Winners in the 2026 Middle East & North Africa Stevie® Awards Announced

    May 4, 2026

    AI Match Predictions, Live Table Projections, and More: Tribuna.com Releases Full Feature Breakdown for the 2026 FIFA World Cup

    April 17, 2026

    Renaissance Services acquires Socat as part of new growth strategy

    April 14, 2026
    Latest News

    OECD inflation eases to 4.2% as lower energy rates take hold

    August 5, 2026

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026

    Guatemala raises red alert as Fuego volcano erupts

    August 5, 2026

    Oil prices fall as Brent and WTI reach three-week lows again

    August 5, 2026

    Eastern Washington fires leave 700 structures destroyed

    August 4, 2026

    Michigan reports first deaths tied to cyclospora outbreak

    August 4, 2026

    Oil prices swing after Brent tops $90 on supply strains

    August 3, 2026

    UK solar capacity reaches 22.8 GW before plug-in launch

    August 3, 2026
    © 2026 Oran Mail | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.